PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25933940-1	2015	The development of a novel, mucus permeating SNEDDS formulation for oral insulin delivery containing a hydrophobic ion pair of insulin/dimyristoyl phosphatidylglycerol (INS/DMPG) is presented.	dimyristoylphosphatidylglycerol	135-167	insulin	Homo sapiens	73-80	
25933940-7	2015	The incorporation of INS/DMPG in SNEDDS prevented an initial burst release of insulin.	dimyristoylphosphatidylglycerol	25-29	insulin	Homo sapiens	78-85	
25933940-9	2015	According to the reported results, the incorporation of the hydrophobic ion pair of INS/DMPG in SNEDDS could be regarded as a promising strategy for the oral delivery of insulin.	dimyristoylphosphatidylglycerol	88-92	insulin	Homo sapiens	170-177